AKBA Stock-Based Compensation
Akebia Therapeutics Inc · Stock-Based Compensation
AKBA Stock-Based Compensation
Latest reported$13.31Mperiod ending
AKBA Stock-Based Comp ($122.00K → $13.31M)
Annual stock-based compensation
High-resolution chart · PNG
AKBA stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 11,283,000 | |
| 7,775,000 | |
| 9,317,000 | |
| 17,849,000 | |
| 22,735,000 | |
| 24,460,000 | |
| 11,925,000 | |
| 19,040,000 | |
| 8,867,000 | |
| 5,825,000 | |
| 4,714,000 | |
| 6,010,000 | |
| 1,563,759 | |
| 122,000 |